130 related articles for article (PubMed ID: 9179260)
1. p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium.
Chaves P; Pereira AD; Pinto A; Oliveira AG; Queimado L; Gloria L; Cardoso P; Mira FC; Soares J
J Surg Oncol; 1997 May; 65(1):3-9. PubMed ID: 9179260
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
6. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
7. No prognostic significance of p53 expression in esophageal squamous cell carcinoma.
Kanamoto A; Kato H; Tachimori Y; Watanabe H; Nakanishi Y; Kondo H; Yamaguchi H; Gotoda T; Muro K; Matsumura Y
J Surg Oncol; 1999 Oct; 72(2):94-8. PubMed ID: 10518106
[TBL] [Abstract][Full Text] [Related]
8. p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions.
Volant A; Nousbaum JB; Giroux MA; Roué-Quintin I; Metges JP; Férec C; Gouérou H; Robaszkiewicz M
J Clin Pathol; 1995 Jun; 48(6):531-4. PubMed ID: 7665695
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma.
Szumilo J; Chibowski D; D browski A
Dis Esophagus; 2000; 13(3):191-7. PubMed ID: 11206631
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389
[TBL] [Abstract][Full Text] [Related]
12. Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein.
Hamada M; Naomoto Y; Fujiwara T; Kamikawa Y; Tanaka N
Jpn J Clin Oncol; 1996 Dec; 26(6):398-404. PubMed ID: 9001343
[TBL] [Abstract][Full Text] [Related]
13. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa.
Mandard AM; Marnay J; Lebeau C; Benard S; Mandard JC
J Pathol; 1997 Feb; 181(2):153-7. PubMed ID: 9120718
[TBL] [Abstract][Full Text] [Related]
15. p53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus.
Fagundes RB; Mello CR; Tollens P; Pütten AC; Wagner MB; Moreira LF; Barros SG
Dis Esophagus; 2001; 14(3-4):185-90. PubMed ID: 11869317
[TBL] [Abstract][Full Text] [Related]
16. Detecting p53 immunoexpression in esophageal mucosa with exfoliative cytology in individuals at risk for squamous cell carcinoma of the esophagus.
Lopes AB; Müller LB; Reichert R; Moraes CM; Capra AM; Prolla JC; Diehl AR; Meurer L; de Barros SG; Fagundes RB
Acta Cytol; 2010; 54(1):31-8. PubMed ID: 20306985
[TBL] [Abstract][Full Text] [Related]
17. Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis.
Okumura T; Shimada Y; Sakurai T; Hori R; Nagata T; Sakai Y; Tsukada K
Dis Esophagus; 2015 Oct; 28(7):634-43. PubMed ID: 24888722
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
[TBL] [Abstract][Full Text] [Related]
20. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.
Zhang H; Li H; Ma Q; Yang FY; Diao TY
World J Gastroenterol; 2016 Oct; 22(39):8770-8778. PubMed ID: 27818592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]